ARCHIVES

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Urocidin May Provide Alternative To Cystectomy in BCG Cancers

May 27, 2011

Cancer Centers Branch To Be ‘More Proactive,’ Kimes Tells NCAB

January 12, 1990

NCI Still Trying To Broaden Group B Drug Distribution

May 5, 1978

In Brief: House Bill Boosts NIH Funding By $1.2 Billion; ASCO Counted More Than 17,000 Registrants

June 26, 1998

Cancer Facts & Figures: Cancer Mortality Down 20 Percent Since 1991

January 25, 2013

Tarceva Added To Gemcitabine Improves Pancreatic Cancer Survival, Study Finds

February 25, 2005